Bifogade filer
ScandiDos receives an order of € 377 500 from Japan
Kurs
+4,44%
Likviditet
0,20 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2025-06-18 | 08:00 | Bokslutskommuniké 2025 |
| 2025-03-12 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2024-12-17 | - | Kvartalsrapport 2025-Q2 |
| 2024-10-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2024-10-23 | - | Årsstämma |
| 2024-09-18 | - | Kvartalsrapport 2025-Q1 |
| 2024-06-18 | - | Bokslutskommuniké 2024 |
| 2024-03-13 | - | Kvartalsrapport 2024-Q3 |
| 2023-12-12 | - | Kvartalsrapport 2024-Q2 |
| 2023-10-18 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2023-10-17 | - | Årsstämma |
| 2023-09-13 | - | Kvartalsrapport 2024-Q1 |
| 2023-06-15 | - | Bokslutskommuniké 2023 |
| 2023-03-08 | - | Kvartalsrapport 2023-Q3 |
| 2022-12-07 | - | Kvartalsrapport 2023-Q2 |
| 2022-10-18 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2022-10-17 | - | Årsstämma |
| 2022-09-13 | - | Kvartalsrapport 2023-Q1 |
| 2022-06-28 | - | Bokslutskommuniké 2022 |
| 2022-03-11 | - | Kvartalsrapport 2022-Q3 |
| 2021-12-14 | - | Kvartalsrapport 2022-Q2 |
| 2021-10-21 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2021-10-20 | - | Årsstämma |
| 2021-09-23 | - | Kvartalsrapport 2022-Q1 |
| 2021-06-29 | - | Bokslutskommuniké 2021 |
| 2021-03-10 | - | Kvartalsrapport 2021-Q3 |
| 2020-12-16 | - | Kvartalsrapport 2021-Q2 |
| 2020-10-07 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2020-10-06 | - | Årsstämma |
| 2020-09-25 | - | Kvartalsrapport 2021-Q1 |
| 2020-06-26 | - | Bokslutskommuniké 2020 |
| 2020-03-10 | - | Kvartalsrapport 2020-Q3 |
| 2019-12-18 | - | Kvartalsrapport 2020-Q2 |
| 2019-10-09 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2019-10-08 | - | Årsstämma |
| 2019-09-12 | - | Kvartalsrapport 2020-Q1 |
| 2019-06-28 | - | Bokslutskommuniké 2019 |
| 2018-12-14 | - | Kvartalsrapport 2019-Q2 |
| 2018-10-03 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2018-10-02 | - | Årsstämma |
| 2018-06-28 | - | Bokslutskommuniké 2018 |
| 2018-03-22 | - | Kvartalsrapport 2018-Q3 |
| 2017-12-15 | - | Kvartalsrapport 2018-Q2 |
| 2017-10-03 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2017-10-02 | - | Årsstämma |
| 2017-09-29 | - | Kvartalsrapport 2018-Q1 |
| 2017-06-28 | - | Bokslutskommuniké 2017 |
| 2017-03-22 | - | Kvartalsrapport 2017-Q3 |
| 2016-12-15 | - | Kvartalsrapport 2017-Q2 |
| 2016-09-21 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2016-09-20 | - | Årsstämma |
| 2016-09-20 | - | Kvartalsrapport 2017-Q1 |
| 2016-06-30 | - | Bokslutskommuniké 2016 |
| 2016-03-15 | - | Kvartalsrapport 2016-Q3 |
| 2015-12-11 | - | Kvartalsrapport 2016-Q2 |
| 2015-09-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2015-09-23 | - | Årsstämma |
| 2015-09-23 | - | Kvartalsrapport 2016-Q1 |
| 2015-06-23 | - | Bokslutskommuniké 2015 |
| 2015-03-26 | - | Kvartalsrapport 2015-Q3 |
| 2014-12-19 | - | Kvartalsrapport 2015-Q2 |
| 2014-10-14 | - | Årsstämma |
| 2014-09-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2014-09-23 | - | Kvartalsrapport 2015-Q1 |
| 2014-06-13 | - | Bokslutskommuniké 2014 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
ScandiDos AB has received an order for € 377 500 for several Delta4 Phantom+ measurement systems. Sales are made through ScandiDos’ well-established distributor Euro Meditech Co. Ltd to a number of hospitals in Japan. These Delta4 Phantom+ systems are expected to be delivered during the remainder of ScandiDos’ fiscal year.
" We are very pleased with another large order from Japan that shows that the Japanese market is recovering well after the Covid pandemic and that ScandiDos in collaboration with Euro Meditech has a very good market position in Japan," says Gustaf Piehl, CEO of ScandiDos.
CONTACT
Gustaf Piehl, CEO, ScandiDos: investor@scandidos.com, +46 18-472 30 20
ScandiDos AB (publ), 556613-0927
Uppsala Science Park, 751 83 Uppsala
ABOUT SCANDIDOS
ScandiDos is an innovative forward-thinking company with groundbreaking software and hardware solutions for patient quality assurance in modern radiation therapy. Our Delta4 Family of products delivers a comprehensive QA solution, making the treatment process safe and efficient. We reinforce the confidence in radiotherapy clinics by providing professionals at the clinics with power and performance through independent QA.
The head office is in Uppsala Science Park, where product development is carried out. Sales are carried out by sales offices in the USA, Malaysia, and France, directly in the Nordic countries and through distributors in over 50 countries.
ScandiDos is listed on NASDAQ First North Stockholm with the ticker code SDOS. Certified adviser is Erik Penser Bank (08-463 83 00, certifiedadviser@penser.se). Additional investor information can be found at Scandidos.com. Product information can be found on Delta4family.com
This information is information that ScandiDos is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-11-01 13:50 CET.